Natalizumab-Related Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis: Findings from an Italian Independent Registry

Immune-reconstitution Inflammatory Syndrome in Multiple Sclerosis Patients Treated With Natalizumab: A Series of 4 Cases

(2016) Rosy N’gbo N’gbo Ikazabo et al.   CLINICAL THERAPEUTICS

Natalizumab-related PML 2 weeks after negative anti-JCV antibody assay

(2016) Marie-Sarah Gagne Brosseau et al.   NEUROLOGY

Diagnostic delay in progressive multifocal leukoencephalopathy

(2016) Dhanashri P. Miskin et al.   Annals of Clinical and Translational Neurology

Revised Recommendations of the Consortium of MS Centers Task Force for a Standardized MRI Protocol and Clinical Guidelines for the Diagnosis and Follow-Up of Multiple Sclerosis

(2015) A. Traboulsee et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Persistence and pathogenesis of the neurotropic polyomavirus JC

(2015) Hassen S. Wollebo et al.   ANNALS OF NEUROLOGY

Neurological immune reconstitution inflammatory response

(2015) David B. Clifford   CURRENT OPINION IN NEUROLOGY

MRI characteristics of early PML-IRIS after natalizumab treatment in patients with MS

(2015) Mike P Wattjes et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Predictors of survival and functional outcomes in natalizumab-associated progressive multifocal leukoencephalopathy

(2015) Tuan Dong-Si et al.   JOURNAL OF NEUROVIROLOGY

MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis—establishing disease prognosis and monitoring patients

(2015)   Nature Reviews Neurology

Progressive multifocal leukoencephalopathy: current treatment options and future perspectives

(2015) Dejan Pavlovic et al.   Therapeutic Advances in Neurological Disorders

Anti-JC virus antibody levels in serum or plasma further define risk of natalizumab-associated progressive multifocal leukoencephalopathy

(2014) Tatiana Plavina et al.   ANNALS OF NEUROLOGY

MRI pattern in asymptomatic natalizumab-associated PML

(2014) Mike P Wattjes et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Outcome and survival of asymptomatic PML in natalizumab-treated MS patients

(2014) Tuan Dong-Si et al.   Annals of Clinical and Translational Neurology

Progressive multifocal leukoencephalopathy in patients with multiple sclerosis

(2013) Kelly J. Baldwin et al.   CURRENT OPINION IN NEUROLOGY

Punctate lesion pattern suggestive of perivascular inflammation in acute natalizumab-associated progressive multifocal leukoencephalopathy: productive JC virus infection or preclinical PML-IRIS manifestation?

(2013) Mike P Wattjes et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Clinically silent PML and prolonged immune reconstitution inflammatory syndrome in a patient with multiple sclerosis treated with natalizumab

(2013) Morten Blinkenberg et al.   Multiple Sclerosis Journal

Natalizumab affects the T-cell receptor repertoire in patients with multiple sclerosis

(2013) C. Warnke et al.   NEUROLOGY

PML diagnostic criteria: Consensus statement from the AAN Neuroinfectious Disease Section

(2013) J. R. Berger et al.   NEUROLOGY

Lessons Learned From Fatal Progressive Multifocal Leukoencephalopathy in a Patient With Multiple Sclerosis Treated With Natalizumab

(2013) Aaron L. Boster et al.   JAMA Neurology

Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy

(2012) Tarek A. Yousry et al.   ANNALS OF NEUROLOGY

Molecular Biology, Epidemiology, and Pathogenesis of Progressive Multifocal Leukoencephalopathy, the JC Virus-Induced Demyelinating Disease of the Human Brain

(2012) M. W. Ferenczy et al.   CLINICAL MICROBIOLOGY REVIEWS

Simultaneous PML-IRIS after discontinuation of natalizumab in a patient with MS

(2012) S. Gheuens et al.   NEUROLOGY

The earlier, the smaller, the better for natalizumab-associated PML: In MRI vigilance veritas?

(2012) R. Phan-Ba et al.   NEUROLOGY

Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring

(2011) Ludwig Kappos et al.   LANCET NEUROLOGY

Natalizumab therapy of multiple sclerosis: recommendations of the Multiple Sclerosis Study Group—Italian Neurological Society

(2011) A. Ghezzi et al.   NEUROLOGICAL SCIENCES

Immune reconstitution inflammatory syndrome in natalizumab-associated PML

(2011) I. L. Tan et al.   NEUROLOGY

Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy

(2011) P. Vermersch et al.   NEUROLOGY

Anti-JC virus antibodies: Implications for PML Risk Stratification

(2010) Leonid Gorelik et al.   ANNALS OF NEUROLOGY

Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases

(2010) David B Clifford et al.   LANCET NEUROLOGY

Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis

(2010) Chen S Tan et al.   LANCET NEUROLOGY

Progressive multifocal leukoencephalopathy in HIV-1 infection

(2009) Paola Cinque et al.   LANCET INFECTIOUS DISEASES

Variations in functioning and disability in multiple sclerosis

(2008) C. Ytterberg et al.   JOURNAL OF NEUROLOGY